BBI Life Sciences Corp. | Mutual Funds
Mutual Funds that own BBI Life Sciences Corp.
Matthews Asia Small Companies Fund
17,482,500
3.2%
2,787,000
1.96%
06/29/2018
Grandeur Peak International Opportunities Fund
15,551,500
2.84%
1,070,000
0.74%
04/30/2018
Grandeur Peak Global Opportunities Fund
13,832,000
2.52%
863,000
0.72%
04/30/2018
HSBC GIF - Asia (ex-Japan) Equity Smaller Companies
13,089,000
2.39%
13,089,000
0.4%
03/31/2018
Grandeur Peak Emerging Markets Opportunities Fund
9,968,500
1.82%
0
0.92%
04/30/2018
Matthews China Dividend Fund
7,221,000
1.32%
2,322,000
0.91%
06/29/2018
Grandeur Peak Global Reach Fund
7,001,500
1.28%
596,000
0.76%
04/30/2018
Hwang Select Asia (ex Japan) Quantum Fund
4,857,000
0.89%
4,857,000
1.58%
02/28/2018
Wasatch World Innovators Fund
3,999,000
0.73%
3,000,000
0.76%
03/31/2018
2,982,500
0.55%
2,699,000
1.88%
06/30/2018
| Address |
No. 698, Xiangmin Road
Shanghai Shanghai 201611
China
|
|
Employees
|
- |
| Website |
http://www.bbi-lifesciences.com |
| Updated |
07/08/2019 |
| BBI Life Sciences Corp. is an investment holding company that engages in the development, manufacture, and sale of various life sciences products used in scientific research. The firm also provides life sciences related services. It operates through the following segments: DNA Synthesis Products, Genetic Engineering Services, Life Sciences Research Consumables, and Protein and Antibody Related Products and Services. |
